Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.
Recruiting · NCT05494034 · Interventional (participants receive a specific treatment) · Lead sponsor: National and Kapodistrian University of Athens
View the official record on ClinicalTrials.gov →Interventions studied
Reveal LINQTM
What this trial is about
In this prospective cohort study, the investigators aim to investigate the incidence of ICM-detected AF in unselected ischemic stroke patients and its association with anticoagulation initiation and stroke recurrence.
Who can take part
Age range
40 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled.
- Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation \[brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan\].
- Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study.
- Informed consent for participation in the study will be obtained from the patients or guardians of patients.
Exclusion criteria
- Patients with incomplete evaluation will be excluded, as previously described. \[22\] -Patients with known or newly detected AF at hospitalization will also be excluded.
- Not providing informed consent.
Where it is running
1 location listed.
- Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece - Athens, Greece